[
    {
        "id": "osp-12417",
        "type": "article-journal",
        "title": "Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient",
        "author": [
            {
                "family": "David",
                "given": "Rathini Lilian"
            },
            {
                "family": "Sen",
                "given": "Parveen"
            }
        ],
        "URL": "https://omanscience.com/ar/articles/secondary-ocular-hypertension-post-intravitreal-dexamethasone-implant-ozurdex-managed-by-pars-plana-implant-removal-along-with-trabeculectomy-in-a-you",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2020
                ]
            ]
        },
        "container-title": "Oman Journal of Ophthalmology",
        "volume": "13",
        "issue": "2",
        "page": "92-94",
        "DOI": "10.4103/ojo.ojo_40_2018",
        "publisher": "Medknow Publications",
        "ISSN": "0974-620X",
        "abstract": "We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy. A young male developed secondary ocular hypertension following dexamethasone implant (OZURDEX) injection for control of posterior uveitis. As the implant was still present in the vitreous cavity, we successfully performed a pars plana removal of the implant along with trabeculectomy with mitomycin C. Early intervention is essential to prevent glaucomatous optic neuropathy in young uveitic patients receiving OZURDEX implant."
    }
]